Hydrochlorothiazide - Important Safety Information from Marketing Authorisation Holders of products containing hydrochlorothiazide as approved by the HPRA

Notice type: 3rd Party Publications

Date: 18/10/2018

 

Problem Or Issue:
Important Safety Information communication from Marketing Authorisation Holders of products containing hydrochlorothiazide - Risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)

Important Safety Information - Hydrochlorothiazide
 


« Back